Fig. 2From: Clinical significance and prognostic value of receptor conversion in hormone receptor positive breast cancers after neoadjuvant chemotherapyPercentage of ER and PR expression pre- and post-NAC for patients with any receptor conversion. a Percentage of ER expression pre- and post-NAC for patients with any receptor conversion. b Percentage of PR expression pre- and post-NAC for patients with any receptor conversion. (ER estrogen receptor, PR progesterone, NAC neoadjuvant chemotherapy) Back to article page